Abstract
A Multi-Center Retrospective Study of Polatuzumab for Patients with Large B-Cell Lymphoma Relapsed after Standard of Care CAR T-Cell Therapy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have